# A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects

> **NCT04556058** · PHASE1 · COMPLETED · sponsor: **Sichuan Haisco Pharmaceutical Group Co., Ltd** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Perindopril tert-Butylamine tablets （ Produced by Haisco）
- **DRUG:** Perindopril tert-Butylamine tablets（ACERTIL®）

## Key facts

- **NCT ID:** NCT04556058
- **Lead sponsor:** Sichuan Haisco Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-29
- **Primary completion:** 2019-03-08
- **Final completion:** 2019-03-15
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04556058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04556058, "A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04556058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*